Abdulkader Puranwala News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abdulkader puranwala. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abdulkader Puranwala Today - Breaking & Trending Today

JB Chemicals looks to double revenue with expansion in the domestic market

JB Chemicals looks to double revenue with expansion in the domestic market
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

South Africa , Abdulkader Puranwala , Contract Development , Manufacturing Organisation , Pharmaceuticals Ltd , Contract Manufacturing Operations ,

Sun Pharma net up 16.5% at ₹2,524 crore on robust sales

Sun Pharmaceutical Industries Ltd reported a consolidated net profit of ₹2,523.75 crore, up 16.5% y-o-y, supported by robust sales, volume growth, and new product launches. ....

Dilip Shanghvi , Abdulkader Puranwala , Sun Pharmaceutical Industries Ltd , Taro Pharmaceuticals , Securities Ltd , Sun Pharmaceutical Industries , Q3 Results ,

Sun Pharma's Move To Fully Acquire Taro Is A Good Proposition, Say Analysts

Sun Pharmaceutical Industries Ltd.'s definitive merger agreement to fully acquire Taro Pharmaceutical Industries Ltd. is a good proposition that adds value for the Indian drugmaker, according to analysts.

Sun Pharma, which owns 78.48% of Taro currently, has agreed to acquire all of the outstanding ordinary shares of Taro not currently held by it. ....

Vishal Manchanda , Abdulkader Puranwala , Sun Pharma , Systematix Corporate Services Ltd , Securities Ltd , Systematix Corporate Services , Sun Pharmaceutical Industries Ltd , Share Price , Nifty Pharma ,

After API subsidiary sale, Glenmark aims to check R&D spends, expand margins

The company’s R&D expenditure will come down to 7-7.5 percent of sales after the disinvestment in Glenmark Lifesciences. It was virtually double, at 14.2 percent of sales, in FY 17-18 ....

Abdulkader Puranwala , Glenmark Lifesciences , Param Desai , Glen Saldhana , Sun Pharma , Glenmark Pharma , Sun Pharmaceuticals , Senior Research Analyst At Prabhudas Lilladher , Glenmark Pharmaceuticals , Glenmark Life Sciences For Rs , Glenmark Life Sciences , Assistant Vice President , New Chemical Entity , Senior Research Analyst , Glenmark Lifesciences ,

glenmark: Glenmark closes 3% lower post API arm sale deal

According to analysts, the sale of Glenmark Life could impact the profitability of Glenmark Pharma in FY25 but lower interest payments could offset the impact. ICICI Securities said the company will use the proceeds to clear its outstanding debt of 4,340 crore as of FY23 but the transaction is likely to result in an earnings cut of 5% for FY25. The brokerage has a sell rating on the stock with a price target of 660. ....

Tushar Manudhane , Rohan John , Glenmark Pharma , Aashita Jain , Kunal Randeria , Abdulkader Puranwala , Glenmark Pharmaceuticals , Glenmark Life Sciences , Motilal Oswal Financial Services , Glenmark Life , Api Arm ,